Login / Signup

The renoprotective effect of once-weekly GLP-1 receptor agonist dulaglutide on progression of nephropathy in Japanese patients with type 2 diabetes and moderate to severe chronic kidney disease (JDDM67).

Ken-Ichi TsuchidaShinji TanedaIsao YokotaKazufumi OkadaYoshio KuriharaHiroki YokoyamaMasahiro IwamotoKatsuya YamazakiYasushi IshigakiNaoki MandaHiroshi Maegawanull null
Published in: Journal of diabetes investigation (2022)
Dulaglutide slowed the eGFR decline in patients with type 2 diabetes and CKD stage 3 to 4.
Keyphrases
  • chronic kidney disease
  • end stage renal disease
  • small cell lung cancer
  • epidermal growth factor receptor
  • tyrosine kinase
  • high intensity
  • early onset
  • diabetic nephropathy